The difference between continuous and intermittent enteral feeding with naso gastric tube in paediatric critically ill children.

COntinuous Versus INtermittent Enteral tube feeding in Critically ill children-An open- label randomized controlled trial - CONVINCE

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068348

Enrollment

146

Registered

2024-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J80- Acute respiratory distress syndrome Health Condition 2: I959- Hypotension, unspecified Health Condition 3: R098- Other specified symptoms and signsinvolving the circulatory and respiratory systems

Interventions

Intervention1: Continuous enteral tube feeding.: Critically ill children satisfying the inclusion and exclusion criteria will be enrolled and randomized into group A and group B. In group A(Interventi

Eligibility

Inclusion criteria

Inclusion criteria: All children between the age of 1 month to less than 15 years, who are likely to stay in PICU for more than 48 hours, not being able to take food orally, enteral nutrition through naso gastric or oro gastric tube for mor than 4 days using standard food formula.

Exclusion criteria

Exclusion criteria: 1.Children with altered Nasogastric tube aspirate 2.Children with enterocolitis 3.Children with surgical abdomen 4.Children with skull base injury. 5.Children with short bowel syndrome 6.Expected death within 24 hours 7. Readmission to PICU more than 48 hours after already having been included in the CONVINCE trial. 8) Transfer from another PICU after stay of more than or equal to 3 days or having received enteral nutrition

Design outcomes

Primary

Measure	Time frame
1.To find the time taken(in days/hours) to reach target calorie (Ã¢â?°Â¥70% of calculated calories as per WHO age sex equation after initiation of feeds) and target protein of 1.5 g/kg/day.Timepoint: Until 1 week of initiation of enteral tube feeding.	—

Secondary

Measure	Time frame
1. To find out the incidence of feeding intolerance,glucose variability Hypoglycemia less than 60gm per dl and hyperglycemia more than 180 mg per dl 2. Incidence and cause of feeding interruption 3. 28 days mortality.Timepoint: 1. To find out the incidence of feeding intolerance,glucose variability Hypoglycemia less than 60gm per dl and hyperglycemia more than 180 mg per dl 2. Incidence and cause of feeding interruption 3. 28 days mortality.	—

Measure

Time frame

1. To find out the incidence of feeding intolerance,glucose variability Hypoglycemia less than 60gm per dl and hyperglycemia more than 180 mg per dl 2. Incidence and cause of feeding interruption 3. 28 days mortality.Timepoint: 1. To find out the incidence of feeding intolerance,glucose variability Hypoglycemia less than 60gm per dl and hyperglycemia more than 180 mg per dl 2. Incidence and cause of feeding interruption 3. 28 days mortality.

—

Countries

India

Contacts

Public ContactDr Manas Ranjan Sahoo

AIIMS Raipur

drmrsahoo@gmail.com7893230151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026